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Abstract
Martha C. Tissot van Patot, Martha C., German Ebensperger, Max Gassmann, and Anı´bal J. Llanos. The hypoxic
placenta. High Alt Med Biol. 13:176–184, 2012. —Hypoxia of the placenta is integral to complications of preg-
nancy, including preeclampsia, intrauterine growth restriction, and small-for-gestational age babies. Hypoxia in
the placenta is associated with vascular remodeling, hypertension, metabolic changes, oxidative stress, mito-
chondrial dysfunction, and endoplasmic reticular stress. Hypoxia induces similar outcomes in other organs such
as the lungs, kidney, and gut. Comparing and contrasting the effects of hypoxia on placental functions and
functions of lung, kidney, and gut can lead to novel hypotheses and investigations, furthering our under-
standing of the impact of hypoxia on these diverse yet similar organs. In this review, we compare and contrast
hypoxic placental responses to those in the other organ and cell systems.
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Introduction
Placental hypoxia is associated with impaired uterineinvasion, poor villous development, loss of vascularity,
reduced spiral artery remodeling, as well as complications of
pregnancy including hypertension, preeclampsia, small-for-
gestational age neonates, and intrauterine growth restriction,
among others. An increasing number of excellent reviews
have focused on hypoxia-mediated placental responses
(Charnock-Jones et al., 2004; Simon et al., 2008; Burton, 2009;
Dunwoodie, 2009; Patel et al., 2010; Pringle et al., 2010; Burton
et al., 2011; Tuuli et al., 2011). So what is new in the present
review? As the placenta’s response to reduced oxygenation
mimics—at least to a given extent—the one found in several
organs including lung, kidney, and gut, we compared the
(patho-) physiological response of the latter organs to the
placenta. Indeed, it was intriguing to observe that oxidative
stress and downstream effects in placental cells are quite
similar to other cells in the body, including the responses of
different organelles such as mitochondria and endoplasmic
reticulum (Burton et al., 2011). We are convinced that com-
paring placental hypoxia-mediated responses to those of
other organ systems and cellular mechanisms will bring
greater understanding of the mechanisms regulating the
placenta’s hypoxic response.
Hypoxic Responses as in the Lung
Vascular remodeling
Hypoxia causes pulmonary and uteroplacental arteries to
have greater vasoconstrictive capabilities than during nor-
moxia, and both vessels are associated with the development
of hypertension. Note that the term ‘vascular remodeling’ has
led to confusion, as it has different meanings depending as
whether this term is used in pulmonary or placental areas of
research. In pulmonary research, ‘vascular remodeling’ de-
scribes the pathophysiologic vascular changes induced by hyp-
oxia, while in placental research it is used to describe
physiologic changes during normoxic exposure. The impact of
hypoxia on placental and pulmonary vasculature, however, is
very similar.
There are two distinct circulations in the placenta, maternal
and fetal. The maternal circulatory system undergoes re-
modeling or ‘physiological conversion’ during development.
In a healthy pregnancy, as the placenta implants into the
uteroplacental wall and oxygen tension increases with
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proximity to the uteroplacental arteries, the involved arteries
are ‘remodeled’. This means that originally muscularized and
vasoreactive vessels become now dilated, nonmuscularized,
and nonvasoreactive. This process insures sufficient blood
flow to the placenta and in turn efficient oxygen and nutrient
delivery to the fetus (Fig. 1).
When a placenta is exposed to lower pO2 during invasion,
as occurs in residents at high altitude or in anemic patients,
physiologic placental remodeling is impaired, resulting in the
presence of more muscularized and vasoreactive vessels
(Tissot van Patot et al., 2003; Cartwright et al., 2007). The
process of physiologic remodeling in the placenta involves
release of a variety of cytokines, matrix metalloproteinases,
and growth factors by the placenta’s decidual cells, thereby
causing dilation of the vessels, followed by invasion of tro-
phoblasts, specialized placental epithelial cells, and uterine
natural killer cells (Harris, 2011). In a fully remodeled uter-
oplacental artery, nonvasoactive trophoblasts replace endo-
thelial cells, and contractile smooth muscle cells are no longer
present. In term placenta, endothelial cells can be found in
some uteroplacental vessels of the basal plate, not only lining
the artery but extending onto the inner surface of the basal
plate (Ockleford, 2010). It is unclear if the uteroplacental ar-
teries are re-endothelialized near term, thereby providing a
means to reduce blood flow during placental delivery or if the
vessels were never fully remodeled.
To come back to our analogy to the lung: many of the fac-
tors governing trophoblast invasion and uteroplacental re-
modeling are also involved in hypoxia-induced pulmonary
vascular remodeling including, but not limited to, HIF alphas,
VEGF, PlGF, IL-6, TGFb, and MAP kinases (Stenmark et al.,
2006; Hanze et al., 2007; Knofler et al., 2011) (Table 1). Pul-
monary vascular remodeling begins with hypoxia-induced
vasoconstriction, followed by medial and adventitial thick-
ening. Increased vessel wall thickness can be attributed to the
presence of an elevated number of smooth muscle cells, many
of which are hypertrophied, and excessive collagen and
elastin deposition (Stenmark et al., 2006) (Fig. 1).
Hypertension
Hypoxia is well known to result in hypertension in the
pulmonary system and in the placental and maternal circu-
lations. Notably, hypertension is prevalent in pregnancies at
high altitude (Moore et al., 1982a; Palmer et al., 1994), leading
a high altitude clinician to comment that ‘‘a pregnancy
without high blood pressure is notable’’ (Lisa Zwerdlinger,
M.D., Leadville, Colorado). Indeed, the placenta plays a key
role in the development ofmaternal hypertension by releasing
multiple vasoconstrictive factors, among those, reactive oxy-
gen species (ROS), HIF-1a, lowered nitric oxide, increased
sensitivity to angiotensin II, endothelin-1, and arachadonic
acid metabolites such as thromboxane (Gilbert et al., 2008), all
of which have also implicated in hypoxia-induced pulmonary
hypertension (Sommer et al., 2008;Ward et al., 2009) (Table 1).
Hypoxic Placenta Outcomes on Fetal/Neonatal Lung
Because the placenta is ultimately responsible for the nur-
turing of the fetus, it is interesting in our analogy to consider
what happens to the fetal pulmonary vascular system in
response to placental hypoxia. Recently, Jayet et al. (2010)
reported that children from preeclamptic pregnancies had
30% greater pulmonary vascular pressure than children from
normotensive pregnancies. In support of these findings, it was
found that the offspring of sheep exposed to high altitude
during pregnancy have more muscularized pulmonary ar-
teries and greater pulmonary vascular pressure than offspring
from low altitude pregnancies (Llanos et al., 2011). Further-
more, pulmonary arteries demonstrated greater sensitivity to
vasoconstrictors, KCl, and endothelin-1, similar to the aug-
mented responses of hypoxic placental and pulmonary
vessels.
Taken together, the molecular and biochemical mecha-
nisms involved in the hypoxic responses of placental and
pulmonary vessels have extensive overlap. Detailed com-
parisons between the hypoxic responses of these organ sys-
tems deserve close scrutiny in lieu of the fact that the common
final outcome, muscularized, hyperreactive, vasoconstrictive
vessels, is associated with diseases that have high incidences
of morbidity and mortality, such as preeclampsia and pul-
monary hypertension. Indeed, the roles of RhoA and RhoA
kinase (ROCK) in the hypoxic lung, but not placenta, have
been extensively researched in recent years. It is now clear that
the RhoA pathway plays a critical role in the pulmonary re-
sponse to hypoxia (Ward et al., 2009). The few investigations
in placenta demonstrate that RhoA/ROCK may be involved
in trophoblast migration (Fafet et al., 2008; Nicola et al., 2008),
but further investigations are necessary to clearly delineate
the role of RhoA/ROCK in the hypoxic placenta.
Conversely, the TRAIL–FASL-mediated apoptotic path-
way has been implicated in compromised placental vascular
remodeling during hypoxia (Whitley et al., 2010), but not in
hypoxia-mediated pulmonary vascular remodeling. Interest-
ingly, TRAIL has been implicated in pulmonary fibroblast
expression of TGFb and collagen production (Yurovsky,
2003). These examples provide support for the value of
FIG. 1. The relationship of oxygen to vascular phenotype in
placenta and lung is depicted. The relative values for low
and high oxygen are related to the ‘normoxic’ oxygen for
each organ, relatively low pO2 in the placenta and relatively
high PO2 in the lung. Low oxygen in these organs yields
vasoconstricted vessels, and the pulmonary system has a
remodeled medial layer to be thickened primarily with
smooth muscle cells. Higher oxygen concentrations yield
dilated vessels in the placenta and lung, and at the ma-
ternoplacental interface endothelial cells are replaced by
nonvasoreactive trophoblast. Green depicts endothelial cells,
blue depicts trophoblasts.
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comparing and contrasting placental responses to hypoxia
with responses of the pulmonary system.
Hypoxic Responses as in the Kidney
The hypoxic placenta produces factors usually considered
the primary domain of the hypoxic kidney, including eryth-
ropoietin (Epo), angiotensin II, and adrenomedullin (ADM)
(Conrad et al., 1996; Marinoni et al., 2007; LaMarca et al.,
2011). For decades it was understood that hypoxia induces
renal Epo production, thus stimulating erythropoiesis. In re-
cent years, it has become clear that Epo has many functions
other than stimulating the production of red blood cells.
Nonerythroid functions include inhibition of apoptosis and
stimulation of inflammatory and pro-angiogenic mechanisms
in multiple organ systems, including the central nervous
system, cardiovascular system, auditory system, retinal sys-
tem, and the pancreas (Grimm et al., 2002; Gassmann et al.,
2003; Chateauvieux et al., 2011). These nonerythroid actions
of Epo serve to protect tissues from hypoxia and ischemic/
reperfusion injury (Mihov et al., 2009; Pappo et al., 2010).
In response to hypoxia, the placenta is also highly capable
of Epo production, and has been reported to synthesize up to
20 times more Epo than the fetal kidney (0.44 vs. 0.18 million
mU per hour) in an ovine model (Davis et al., 2003). Other
than increasing fetal hemoglobin, nonhematopoietic Epo ac-
tions have the potential to positively or adversely affect pla-
cental and fetal development. For example, apoptosis is a key
physiologic mechanism in normal fetal development and
uteroplacental artery invasion and remodeling. Epo’s pro-
angiogenic actions might improve placental vascularity, thus
elevating gas exchange between fetus and mother during
hypoxia. Further, ischemic reperfusion injury (Burton et al.,
2004) and elevated placental Epo concentrations (Teramo
et al., 2004) have been associated with preeclampsia, a disease
of pregnancy that involves reduced oxygen supply to this
organ. Reports of Epo-mediated protection of ischemic re-
perfusion injury in heart and liver (Mihov et al., 2009; Pappo
et al., 2010) suggest that elevated placental Epo production
may be of benefit in preeclampsia.
Adaptation of highlanders
In the kidney, hypoxia-induced Epo production is pri-
marily mediated by hypoxia inducible factor - 2 (HIF-2)
(Rankin et al., 2007). In the placenta, hypoxia led to greater
accumulation of HIF-2a but not of HIF-1a (Genbacev et al.,
2001, Tissot van Patot et al., 2004). Interestingly, polymor-
phisms of EPAS1, the gene encoding HIF-2, were recently
reported in Tibetans highly adapted to residence at extreme
altitudes. These polymorphisms were highly associated with
low hemoglobin concentration in the Tibetan population (re-
viewed in Tissot van Patot et al., 2011). In other words: the
kidney likely has less HIF-2/Epo expression in this adapted
population. Tibetans also experience a much lower incidence
of preeclampsia and low birth weight at high altitude, com-
paredwith theHan population, who represent Chinese native
to low altitude ( Julian et al., 2009). Placental function is inti-
mately involved in the development of preeclampsia and
birth weight, and Epo is implicated in the development of
preeclampsia and reduction of bodyweight (Katz et al., 2010).
It is quite possible that the EPAS1 adaptation extends to pla-
centas from healthy, but not preeclamptic or low birth weight,
pregnancies at high altitude.
EGLN1 is the gene encoding prolyl hydroxylase 2 (PHD2)
that in turn inhibits the a subunits of HIFs by targeting them
for ubiquination. PHD2 is specific for inhibition of Epo pro-
duction in kidney (Minamishima et al., 2010). Severe placental
defects in PHD2-deficient mice result in highly elevated HIF
concentrations and embryonic lethality between E12.5–E14.5
(Takeda et al., 2006). Interestingly, a mutation of the EGLN1
gene is reported in Andean populations (Peng et al., 2011)
Table 1. Molecular Pathways Involved in Placental and/or Pulmonary Vasoconstriction
and Vascular Remodeling in Response to Hypoxia
Location
Placenta Lung
Vasoconstriction/
Vascular Remodeling References
X X ROS (Stenmark et al., 2006, Gilbert et al., 2008, Ward et al., 2009, Burton et al., 2011)
X X NO (Stenmark et al., 2006, Gilbert et al., 2008)
X X ET-1 (Stenmark et al., 2006, Gilbert et al., 2008)
X X RhoA/ROCK (Ward et al., 2009)
X X Thromboxane (Sommer et al., 2008, Gilbert et al., 2009, Ward et al., 2009)
X X PI3K-AKT (Gerasimovskaya et al., 2005, Park et al., 2010)
X X Kv Channels (Wareing et al., 2006, Sommer et al., 2008, Ward et al., 2009, Mistry et al., 2011)
X X L-type Ca2 + Channels ( Jakoubek et al., 2006, Sommer et al., 2008)
X X NADPH (Sommer et al., 2008, Burton et al., 2011)
X X HIF-1a (Pak et al., 2007, Lee et al., 2010)
X X VEGF (Pak et al., 2007, Gilbert et al., 2008, Myatt et al., 2009)
X X PLGF (Pak et al., 2007, Gilbert et al., 2008, Myatt et al., 2009)
X X IL-6 (Bowen et al., 2005, Gilbert et al., 2008)
X X Angiotensin (Gilbert et al., 2008, Gonzalez et al., 2010)
X X sFlt-1 (Gilbert et al., 2008, Myatt et al., 2009)
X X TGFb (Lee et al., 2010, Gong et al., 2011, Nasim et al., 2012)
X X MAP kinases (Pak et al., 2007, Harris 2011,, Nasim et al., 2012)
X X TRAIL/FasL (Whitley et al., 2010)
X X MMPs (Harris et al., 2010, Lee et al., 2010, Chelladurai et al., 2012)
References are primarily reviews discussing the role of the specific factor in the placenta or lung during hypoxia.
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who are well adapted to high altitude and—unlike the
Tibetans—Andeans such as Quechuas and Aymaras have
high hemoglobin concentrations (Beall et al., 1998). These data
suggest that the EGLN1 mutation lowers PHD2, leading to
elevated renal production of HIF2 and Epo. Accordingly,
Andeans do not demonstrate the mutation in the EPAS1 gene
that is present in Tibetans (Beall et al., 2010).
In summary, genomic analyses suggest that Tibetans have
adapted to altitude by mutating EPAS1, reducing HIF-2, Epo,
and hemoglobin concentrations, while Andeans have adapted
by mutating PHD2, increasing HIF-2, Epo, and hemoglobin
concentrations. Such variability in placental Epo concentra-
tions would result in greatly differing placental morphology
and functions between these adapted populations. Further
studies are urgently needed to discover how such differing
genetic mutations can each result in successful adaptations
and pregnancies in high altitude native populations.
Impact on blood pressure
Hypoxia not only increases renal and placental Epo pro-
duction, but hypoxia or Epo alone induces activity of the re-
nin–angiotensin system (RAS) in a variety of ways. The RAS
increases blood pressure directly via receptors in the vascular
system and indirectly by increasing blood volume via reten-
tion of sodium in the kidney. In the placenta, Epo increases
vasoconstriction via the angiotensin I (AT1) receptor pri-
marily in placental veins delivering blood to the fetus (Resch
et al., 2003). Placental hypoxia increases angiotensin II pro-
duction (Knock et al., 1994), activity of angiotensin converting
enzyme (ACE) (Ito et al., 2002), and AT1 receptor agonist
autoantibodies (Wallukat et al., 1999), all of which are ele-
vated in preeclamptic placentas (Herse et al., 2008). Activation
of angiotensin receptors in the placenta increase vasocon-
striction of veins delivering blood to the fetus (Resch et al.,
2003), decreases trophoblast differentiation and invasion
(Araki-Taguchi et al., 2008), increases reactive oxygen species
(ROS) via NADPH oxidase and increases NFjB and thus in-
flammation (Dechend et al., 2003) , all of which are implicated
in preeclampsia.
In the kidney, hypoxia and/or Epo stimulate an increase in
angiotensin II, which in turn leads to an increase in systemic
blood pressure. As in the hypoxic placenta, angiotensin II can
also cause cellular damage by initiating oxidative stress (Palm
et al., 2011). Thus, the RAS has been implicated in the devel-
opment of renal allograft rejection, renovascular disease, and
malignant hypertension. Interestingly, AT1 receptor agonist
autoantibodies are elevated in these conditions and blocking
receptor binding can reduce blood pressure and kidney
damage (LaMarca et al., 2011). Angiotensin II blockade or
ACE inhibition can also reduce blood pressure and kidney
damage (Lebel et al., 2006), however the hematocrit also falls
in patients treated this way (Qureshi et al., 2007). Delivery of
ACE inhibitors during pregnancy is not advised due to in-
creased risk of major congenital malformations (first trimes-
ter) and elevated risk of fetopathies (second and third
trimesters) (Cooper et al., 2006).
As expected by the highly variable data from hypoxic
kidneys cited above, epidemiologic studies of kidney function
at high altitude have variable results. Some studies show al-
titude residents having a greater disposition toward a syn-
drome referred to as high altitude renal syndrome (Arestegui
et al., 2011) and development of chronic kidney disease (Chen
et al., 2011), while others demonstrate a beneficial effect of
altitude by decreased mortality in dialysis patients (Winkel-
mayer et al., 2009) and a protective effect in chronic kidney
disease patients (Ghahramani et al., 2011). The kidney and
placenta play important roles in control of blood pressure in
response to hypoxia. However, the hypoxic responses also
cause damage to the cells and organ systems. The similarities
between these two organ systems in their mechanisms of
hypoxic response go far beyond those that are highlighted
here and include nitric oxide, generation of reactive oxygen
species, and changes in mitochondrial function. The resulting
hypertension and end organ dysfunction have high rates of
mortality and there is great potential for similar therapeutic
interventions to work on both organ systems.
Hypoxic Responses as in the Gut
Placental function mimics gut function by selectively de-
livering nutrients from the maternal circulation to the fetus.
Hypobaric hypoxia results in lower birth weight (Lichty et al.,
1957; Moore et al., 1982b) and loss of weight in response
in adults (Westerterp et al.,1992; Lippl et al., 2010). Un-
fortunately, present data regarding placental expression of
glucose transporter 1 (GLUT1) during hypoxia are variable
and inconclusive (Hayashi et al., 2004; Zamudio et al., 2010). It
is likely that the reduction in fetal glucose concentrations at
high altitude, associated with lower birth weight, is due to a
combination of factors. Moore et al. (2011) have demonstrated
significant altitude-associated reduction in uterine artery
blood flow, thus delivering less glucose to the placenta and
fetus, while Zamudio et al. (2010) suggest that the placenta
increases glucose uptake, thus ‘robbing’ the fetus of glucose at
high altitude. Recent metabolomics data, however, do not
reveal direct evidence of greater placental glycolysis in high as
compared to low altitude placentas, yet altitude placentas did
demonstrate a tendency toward storing energy in the form of
phosphocreatine (Tissot van Patot et al., 2010). Furthermore,
placental hormonal factors, including leptin and ghrelin, are
associated with low birth weight in preeclampsia (Aydin
et al., 2008) at high altitude (Trollmann et al., 2007).
Similar to the reduction in birth weight when pregnancy
occurs at high altitude, ascent to altitude in human subjects
results in reduced bodyweight. Themechanism ofweight loss
at altitude remains unknown, yet gastrointestinal blood flow
does not appear to be a factor (Kalson et al., 2010), while the
roles of leptin and ghrelin are disputed (Quintero et al., 2010;
Aeberli et al., 2012). These authors discuss additional mech-
anisms of hypoxia-induced weight loss that have been im-
plicated, including loss of appetite, poor nutrient absorption,
and inflammation (Quintero et al., 2010), some of which de-
serve investigation in the phenomenon of low birth weight at
high altitude.
The Common Denominator: Oxidative Stress
Hypoxia results in oxidative stress, generation of reactive
oxygen species (ROS), and initiation of multiple molecular
cascades, resulting in a myriad of biological outcomes, in-
cluding hypertension, vascular remodeling, erythropoiesis,
angiogenesis, glycolysis, and many others. ROS can activate
physiologic processes to protect cells from hypoxia as well as
pathologic process that damage organs. These molecular
cascades initiated by ROS include activation of a variety of
transcription factors and protein kinases, opening ion chan-
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nels, protein modifications, lipid peroxidation, and DNA ox-
idation (Burton et al., 2011). In pathological conditions, ROS-
initiated pathways can lead to vascular remodeling, hyper-
tension, altered cellular differentiation or proliferation, im-
paired cellular transport, reduced enzyme kinetics, and many
more. Chronic exposure to ROS impacts the placenta and is
involved in the development of intrauterine growth restriction,
preeclampsia, and spontaneous miscarriage (Burton et al.,
2011), largely by impairing uteroplacental artery remodeling,
uterine invasion, and vascular development. Similarly, the ef-
fects of ROS on pulmonary, renal, and gastrointestinal systems
can contribute to the development of pulmonary hypertension,
chronic kidney disease, and inflammatory bowel disease.
Mitochondria generate ROS during hypoxia, which in turn
mediate cellular response to hypoxia (Hamanaka et al., 2010).
The complexity of the system and overlap in function is ex-
treme. For example, mitochondrial ROS activate stabilization
of hypoxia-inducible transcription factors (HIFs) (Fandrey
et al., 2006) and HIFs mediate mitochondrial respiration
during hypoxia (Chandel et al., 2000). There is also a close
relationship between oxidative stress, mitochondrial re-
sponse, and the endoplasmic reticulum (ER). Because protein
metabolism is responsible for about 30% of cellular oxygen
consumption, it is vital for the ER to communicate with the
mitochondria during hypoxic stress (Burton et al., 2011). In
the placenta, it was recently reported that hypobaric hypoxia
created ER stress, activating the unfolded protein response,
thus modulating protein synthesis in placentas, possibly
contributing to the reduced villous volume in high altitude
placentas and the resultant lower birth weight (Yung et al.,
2012). Hypoxic activation of the unfolded protein response in
endoplasmic reticulum has also been reported in hypoxic
kidneys (Inagi, 2010) and endothelium (Bouvier et al., 2009).
Translational science: How does the hypoxic placenta
affect the fetus?
When hypoxia creates pathologies in the lungs, kidney, and
gut, the patient suffers illness and disease. When hypoxia
creates pathophysiology in the placenta, the fetus may suffer
developmental pathologies. It has recently been reported that
children from preeclamptic pregnancies at high altitude have
elevated pulmonary artery pressures ( Jayet et al., 2010). Si-
milarly, we have reported elevated pulmonary artery pres-
sures and differences in responses to vasoactive substances in
an ovine offspring from high altitude pregnancies (Herrera
et al., 2010; Llanos et al., 2011; Moraga et al., 2011). These data
strongly suggest that a hypoxic placenta produces long-last-
ing changes in fetal physiology.
We have recently extended these studies to the cardiovas-
cular system, hypothesizing that the cardiovascular basal
status and cardiovascular defense responses to acute hypoxia
in lowland fetal sheep grown at high altitude are blunted in
comparison to fetuses that underwent gestation at sea level.
Using a protocol similar to that previously reported (Herrera
et al., 2010; Moraga et al., 2011), we studied fetal at day 130 of
gestation (87% gestation) at 580 meters above sea level
(LALA) and fetal sheep from lowland taken to 3600 meters
above sea level at 45–50 days of gestation (30% gestation)
(LAHA). To summarize our findings, in fetuses whose ges-
tation took place partially in chronic hypoxia (LAHA) we
found that:
1. Three out of 7 LAHA fetuses died in utero prior to the
age of catheterization and there was marked fetal
Table 2. pH and Arterial Blood Gases in Ascending
Aorta in Fetal Sheep Basally and During
Acute Hypoxia
Basal Hypoxemia Recovery
pH LALA 7.385 – 0.010# 7.325– 0.022 7.317– 0.019
LAHA 7.425 – 0.017* 7.400– 0.006 7.400– 0.013*
pCo2 LALA 45.6 – 1.0 43.7 – 1.3 43.4 – 1.2
mmHg LAHA 43.2 – 1.4 40.7 – 1.0 38.8 – 1.6*{
pO2 LALA 21.0 – 0.8 12.6 – 0.4# 21.5 – 0.9
mm Hg LAHA 14.5 – 1.2* 11.2 – 1.0# 15.0 – 1.3*
Hb LALA 10.0 – 0.3 10.3 – 0.4 9.7 – 0.5#
g/dL LAHA 11.6 – 0.7* 11.7 – 0.7* 11.3 – 0.7*
satHb% LALA 56.2 – 1.6 25.5 – 2.3# 50.8 – 2.8
LAHA 41.4 – 6.3* 25.5 – 4.7*# 37.9 – 5.3*
O2 cont LALA 7.6 – 0.1 3.6 – 0.3# 6.7 – 0.4
mlO2/dL LAHA 6.4 – 0.6 4.0 – 0.5# 5.9 – 0.4
Values are means– SEM taken at 15 and 45min of basal, each
15min during hypoxemia, and 15 and 45min of recovery. Significant
differences ( p £ 0.05).
{, vs. basal period; #, vs. all periods in the same experimental
group; *, vs. LALA fetuses.
FIG. 2. Mean systemic arterial pressure (SAP; Panel A) and
heart rate (HR; Panel B) in sheep fetuses whose conception
and 87% of pregnancy took placed at low altitude (LALA;
open circles) and sheep fetuses whose conception took placed
at low altitude and pregnancy at high altitude (3600m), from
30% of gestation until 87% of gestation (LAHA; closed circles).
Values are means – SEM. Significant differences ( p< 0.05) are
as follows: SAP; Panel A: { LALA fetuses vs. Basal period; *,
LAHA vs. LALA fetuses; HR; Panel B: { LALA fetuses vs.
Basal period; *, LALA vs. LAHA fetuses; #, LAHA fetuses vs.
all periods in the same experimental group.
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growth retardation. In contrast, all the sea level preg-
nancies (LALA) had 100% survival. The striking de-
crease in PO2 in LAHA fetal sheep can explain the
marked fetal growth restriction and mortality in these
fetuses (Table 2).
2. No bradycardia was seen as response to hypoxia. In
contrast, there was an increased heart rate, evidencing
an absent chemoreflex with a diminished vagal response
plus an augmented sympathetic outcome (Fig. 2).
3. Basally, there was an increased carotid blood flow, as
the result of the low PO2 in the arteries supplying the
central nervous system, probably due to an increased
NO production, among other mediators (Fig. 3).
4. The systemic arterial pressure and carotid blood flow
showed blunted responses to acute hypoxemia, re-
sponses observed even during the recovery period
(Figs. 2 and 3).
We speculate that the observed blunting in the cardiovas-
cular responses in chronically hypoxic fetuses reflects the
expression of a hypometabolic state in the tissues, fingering
the main regulation at cellular and tissue levels with little
need of major cardiovascular adjustments to cope with acute
changes in PO2.
These data support the hypothesis that a hypoxic placenta
can have a strong influence on the health of the fetus, similar
to the way in which hypoxic organs negatively impact the
health of the individual.
Conclusion
In its role of supporting fetal development, the placenta
must fulfill the actions of many physiologic processes, in-
cluding the delivery of oxygen and nutrients, removal of
waste products, blood pressure control, and hormone pro-
duction. Hypoxia stresses the placenta’s ability to perform
these functions in a manner similar to hypoxia-induced
stress created in other organs responsible for similar func-
tions such as the lungs, gut, and kidneys. Furthermore, at the
cellular level, hypoxia-induced oxidative stress activates
similar cascades in trophoblast and vascular endothelial
cells, smooth muscle cells, and fibroblasts in multiple organ
types. Comparing and contrasting these molecular cascades
and the resulting hypoxia-induced pathophysiologies in
various organ systems will likely stimulate further investi-
gations into the etiology and outcome of placental hypoxia,
leading to a greater understanding of placental-mediated
diseases.
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